SCHEMBL29876809

SCHEMBL29876809

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.70
NR5A2 O00482 2/20 0.69
NR5A1 Q13285 2/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
MAPT P10636 1/20 0.62
RECQL P46063 1/20 0.55
FABP3 P05413 1/20 0.55
SELP P16109 1/20 0.51
S1PR1 P21453 1/20 0.46
ADRA1D P25100 1/20 0.46
PTAFR P25105 1/20 0.46
HTR1D P28221 1/20 0.46
HTR2C P28335 1/20 0.46
ADRA1B P35368 1/20 0.46
DRD3 P35462 1/20 0.46
TMEM97 Q5BJF2 1/20 0.46
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30651167 1.00 ALDH1A1 (0.70) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL19864321 1.00 ALDH1A1 (0.70) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL30652068 0.99 ALDH1A1 (0.72) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL25700291 0.99 ALDH1A1 (0.72) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL29935660 0.99 ALDH1A1 (0.72) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL31616183 0.99 ALDH1A1 (0.72) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL30649867 0.99 ALDH1A1 (0.72) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL30536890 0.98 ALDH1A1 (0.73) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL31615955 0.97 ALDH1A1 (0.75) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT
SCHEMBL30652751 0.97 ALDH1A1 (0.75) ALDH1A1NR5A2NR5A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120114222-A Use of plasma inhalation for improving body metabolism 北京市神经外科研究所 2025-06-10 CN disclosed
EP-4522646-A2 APOE LIPOPROTEIN SYSTEMS Kisbee Therapeutics, Inc. (US) 2025-03-19 EP disclosed
WO-2023220387-A2 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed